Adjuvant Chemotherapy +/- Cemiplimab and Sequential Hypofractionated Radiotherapy in Unfit or Elderly Patients With Stage III Lung Cancer

Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2024
The use of neoadjuvant immuno-chemotherapy could improve survival outcomes of patients eligible for sequential radio-chemotherapy comparing to the benefit already obtained with maintenance immunotherapy.
Epistemonikos ID: 67f023999c924297e7be186d1bfa86360b3ce9ac
First added on: Apr 17, 2025